Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as of August 2026.

Metatag Title
World Largest HealthCare Products Companies in 2026
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2026, World Largest HealthCare Products Companies by Market Cap in 2026.
  1. Surgery Partners

    World Rank (Aug-2026)
    6,385
    Market Cap (Aug-2026)
    1.968 Billion USD
    World Rank (Jan-05-2024)
    3,603
    Market Cap (Jan-05-2024)
    3.853 Billion USD
    World Rank (Jul-30-2023)
    3,061
    Market Cap (Jul-30-2023)
    4.829 Billion USD
    World Rank (Dec-25-2022)
    4,058
    Market Cap (Dec-25-2022)
    3.025 Billion USD
    World Rank (Jan-07-2022)
    3,864
    Market Cap (Jan-07-2022)
    4.05 Billion USD
    Annual Revenue in USD
    3,309 Million USD
    Annual Operating Income in USD
    390 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Surgery Partners is a operator of surgical facilities and ancillary services provides Healthcare Experiences between providers and patients with more than 180 locations nationwide. The company services are comprised of a diagnostic laboratory, multi specialty physician practices and anesthesia services. The headquarters is in USA.

  2. AstraZeneca Pharma India

    World Rank (Aug-2026)
    6,457
    Market Cap (Aug-2026)
    1.937 Billion USD
    World Rank (Jan-05-2024)
    6,265
    Market Cap (Jan-05-2024)
    1.701 Billion USD
    World Rank (Jul-30-2023)
    7,946
    Market Cap (Jul-30-2023)
    1.174 Billion USD
    World Rank (Dec-25-2022)
    8,369
    Market Cap (Dec-25-2022)
    0.996 Billion USD
    World Rank (Jan-07-2022)
    9,367
    Market Cap (Jan-07-2022)
    1.01 Billion USD
    Annual Revenue in USD
    101 Million USD
    Annual Net Income in USD
    8 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    AstraZeneca Pharma India is a healthcare company focused on the areas like cardiovascular, renal & metabolic diseases, oncology and respiratory. The company annual revenue is 8,056 million INR and annual net income is 615 million INR for year ending March 2022. The headquarters is in India.
  3. Eris Lifesciences

    World Rank (Aug-2026)
    6,487
    Market Cap (Aug-2026)
    1.923 Billion USD
    World Rank (Jan-05-2024)
    6,710
    Market Cap (Jan-05-2024)
    1.518 Billion USD
    World Rank (Jul-30-2023)
    7,521
    Market Cap (Jul-30-2023)
    1.283 Billion USD
    World Rank (Dec-25-2022)
    7,956
    Market Cap (Dec-25-2022)
    1.092 Billion USD
    World Rank (Jan-07-2022)
    7,843
    Market Cap (Jan-07-2022)
    1.37 Billion USD
    Annual Revenue in USD
    166 Million USD
    Annual Net Income in USD
    51 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Eris Lifesciences is a pharmaceutical company with a generation of actionable medical evidence through initiatives such as the India Heart Study (IHS) and India Diabetes Study (IDS). The company annual revenue is 13,470 million INR and annual net income is 4,061 million INR for year ending March 2021. The headquarters is in India.
  4. Zhejiang Wolwo Bio-Pharmaceutical

    World Rank (Aug-2026)
    6,494
    Market Cap (Aug-2026)
    1.921 Billion USD
    World Rank (Jan-05-2024)
    5,645
    Market Cap (Jan-05-2024)
    2.021 Billion USD
    World Rank (Jul-30-2023)
    4,444
    Market Cap (Jul-30-2023)
    2.917 Billion USD
    World Rank (Dec-25-2022)
    3,406
    Market Cap (Dec-25-2022)
    3.835 Billion USD
    World Rank (Jan-07-2022)
    3,670
    Market Cap (Jan-07-2022)
    4.31 Billion USD
    Annual Revenue in USD
    117 Million USD
    Annual Net Income in USD
    49 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  5. Sarepta Therapeutics

    World Rank (Aug-2026)
    6,508
    Market Cap (Aug-2026)
    1.912 Billion USD
    World Rank (Jan-05-2024)
    1,838
    Market Cap (Jan-05-2024)
    8.820 Billion USD
    World Rank (Jul-30-2023)
    1,662
    Market Cap (Jul-30-2023)
    10.109 Billion USD
    World Rank (Dec-25-2022)
    1,373
    Market Cap (Dec-25-2022)
    11.407 Billion USD
    World Rank (Jan-07-2022)
    2,400
    Market Cap (Jan-07-2022)
    7.45 Billion USD
    Annual Revenue in USD
    1,864 Million USD
    Annual Operating Income in USD
    -700 Million USD
    Annual Net Income in USD
    -713 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Biotechnology company with headquarters is in Massachusetts, USA.

  6. Nantkwest

    World Rank (Aug-2026)
    6,535
    World Rank (Jan-05-2024)
    6,535
    World Rank (Jul-30-2023)
    6,535
    World Rank (Dec-25-2022)
    6,535
    World Rank (Jan-07-2022)
    6,535
    Annual Revenue in USD
    113 Million USD
    Annual Operating Income in USD
    -256 Million USD
    Annual Net Income in USD
    -351 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    NantKwest is an innovative Clinical Stage Immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. It is having 161 employees as on 2019. The headquarters is in USA.
  7. Galapagos NV

    World Rank (Aug-2026)
    6,542
    Market Cap (Aug-2026)
    1.890 Billion USD
    World Rank (Jan-05-2024)
    4,681
    Market Cap (Jan-05-2024)
    2.719 Billion USD
    World Rank (Jul-30-2023)
    4,598
    Market Cap (Jul-30-2023)
    2.788 Billion USD
    World Rank (Dec-25-2022)
    4,345
    Market Cap (Dec-25-2022)
    2.778 Billion USD
    World Rank (Jan-07-2022)
    4,426
    Market Cap (Jan-07-2022)
    3.40 Billion USD
    Annual Revenue in USD
    593 Million USD
    Annual Net Income in USD
    -114 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    GALAPAGOS NV is a clinical-stage biotechnology, pharmaceutical research company. The headquarters is in Belgium. 

  8. LeMaitre Vascular Inc.

    World Rank (Aug-2026)
    6,559
    Market Cap (Aug-2026)
    1.884 Billion USD
    World Rank (Jan-05-2024)
    7,685
    Market Cap (Jan-05-2024)
    1.207 Billion USD
    World Rank (Jul-30-2023)
    7,192
    Market Cap (Jul-30-2023)
    1.396 Billion USD
    World Rank (Dec-25-2022)
    8,322
    Market Cap (Dec-25-2022)
    1.008 Billion USD
    World Rank (Jan-07-2022)
    9,300
    Market Cap (Jan-07-2022)
    1.02 Billion USD
    Annual Revenue in USD
    250 Million USD
    Annual Operating Income in USD
    68 Million USD
    Annual Net Income in USD
    58 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    LeMaitre Vascular is a Innovator, Manufacturer and Marketer of Devices company for the Treatment of Peripheral Vascular Disease. The headquarters is in USA.

    Facts About Company

    LeMaitre Vascular company annual revenue was 161.6 million USD and annual operating income was 29.9 million USD and annual net income was 20.6 million USD for year ending Dec-2022.

    LeMaitre Vascular had 617 employees as on 2022.

  9. Global Blood Therapeutics

    World Rank (Aug-2026)
    6,607
    World Rank (Jan-05-2024)
    6,607
    World Rank (Jul-30-2023)
    6,607
    World Rank (Dec-25-2022)
    6,607
    World Rank (Jan-07-2022)
    6,607
    Market Cap (Jan-07-2022)
    1.85 Billion USD
    Annual Revenue in USD
    195 Million USD
    Annual Operating Income in USD
    -288 Million USD
    Annual Net Income in USD
    -303 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    Company Profile

    Global Blood Therapeutics is a Biopharmaceutical Company. It is to transform the treatment of sickle cell disease and an overlooked rare condition and help address the urgent needs of the community. The company medicine is the first treatment approved by the FDA to target an underlying cause of SCD. The headquarters is in USA.

  10. Bora Pharmaceuticals

    World Rank (Aug-2026)
    6,688
    Market Cap (Aug-2026)
    1.821 Billion USD
    World Rank (Jan-05-2024)
    5,385
    Market Cap (Jan-05-2024)
    2.185 Billion USD
    World Rank (Jul-30-2023)
    5,383
    Market Cap (Jul-30-2023)
    2.211 Billion USD
    World Rank (Dec-25-2022)
    8,391
    Market Cap (Dec-25-2022)
    0.993 Billion USD
    World Rank (Jan-07-2022)
    14,523
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Headquarters Country

Share

Ads